Sign In
Buy ABEO
$6.42
-0.0500 (-0.773%)
At Close: Jul 31, 2026
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Abeona Therapeutics (
ABEO
–
Research Report
), Teva Pharmaceutical Industries (
TEVA
–
Research Report
) and Capr
RDS.A, ARNC among top premarket gainers
01:22pm, Thursday, 02'nd Apr 2020
ION Geophysical (NYSE:IO) +120% on expecting big jump in Q1 revenues.Neptune Wellness Solutions (NASDAQ:NEPT) +47% on receiving health Canada authorization to commercialize natural, plant-based hand
Regenxbio: A Growth Stock For The Coronavirus Bear Market
10:14am, Wednesday, 01'st Apr 2020
Amid this coronavirus bear market, I strongly believe that you should build shares in fundamentally sound companies. Accumulating stocks in a bear market takes
uniQure to Participate in Multiple Upcoming Investor Conferences in April | MarketScreener
11:01am, Monday, 30'th Mar 2020
Mar 30, 2020 (The Expresswire) --
Global "Malonic Acid Market" compromises many advantages that have accelerated the adoption of absorption among various...
Abeona Therapeutics Stakeholder Letter in Response to the COVID-19 Pandemic
10:19pm, Friday, 27'th Mar 2020
The COVID-19 pandemic has created extraordinary challenges across all aspects of healthcare. Above all, we will take every reasonable measure to ensure the safety of our patients and employees, while
The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates
11:36am, Wednesday, 18'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 17) * BioNTech SE - ADR (NASDAQ: BNTX) * Regeneron P
Analysts Conflicted on These Healthcare Names: Abeona Therapeutics (ABEO) and AbbVie (ABBV)
08:11am, Wednesday, 18'th Mar 2020
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Abeona Therapeutics (ABEO) and AbbVie (ABBV). Abeona
Analysts Conflicted on These Healthcare Names: Abeona Therapeutics (NASDAQ: ABEO) and AbbVie (NYSE: ABBV)
08:11am, Wednesday, 18'th Mar 2020
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Abeona Therapeutics (ABEO
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 16.) * BioNTech SE - ADR (NASDAQ: BNTX) (announced eff
Abeona Therapeutics Inc. (ABEO), a fully-integrated leader in gene and cell therapy, today announced that investigators at Stanford University Medical Center have treated the first patient in the pivo
Abeona Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Business Updates
08:20pm, Monday, 16'th Mar 2020
On track to treat first RDEB patient in pivotal Phase 3 VIITAL™ study of EB-101 in Q1 2020 Positive interim data from MPS IIIA and MPS IIIB programs presented at.
Is Earthstone (ESTE) Likely to Beat Q4 Earnings Estimates?
05:18pm, Tuesday, 10'th Mar 2020
Earthstone Energy's (ESTE) fourth-quarter earnings are likely to have been aided by higher oil production.
Borough mayor thanks volunteers for supporting their community - The Wokingham Paper
06:00am, Saturday, 29'th Feb 2020
“I’ve met so many unsung heroes and would like to take this opportunity to thank them for their continued commitment to those less fortunate than ourselves.”
Abeona Therapeutics to Present at the 9th Annual SVB Leerink Global Healthcare Conference
01:00pm, Wednesday, 26'th Feb 2020
NEW YORK and CLEVELAND, Feb. 26, 2020 -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced that João Siffert, M.D.,.
